Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
- Conditions
- Chronic Ischemic Stroke
- First Posted Date
- 2015-05-19
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- SanBio, Inc.
- Target Recruit Count
- 163
- Registration Number
- NCT02448641
- Locations
- 🇺🇸
University of Alabama at Birmingham (Surgical/Assessment), Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Xenoscience, Inc. (Assessment), Phoenix, Arizona, United States
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
- Conditions
- Traumatic Brain Injury
- First Posted Date
- 2015-04-15
- Last Posted Date
- 2021-12-27
- Lead Sponsor
- SanBio, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT02416492
- Locations
- 🇺🇸
UCLA Medical Center (Surgical/Assessment), Los Angeles, California, United States
🇺🇸Ronald Reagan UCLA Medical Denter, Los Angeles, California, United States
🇺🇸The Research Center of Southern California, LLC (Assessment), Oceanside, California, United States
A Study of Modified Stem Cells in Stable Ischemic Stroke
- Conditions
- Chronic Ischemic Stroke
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- SanBio, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01287936
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Stanford University School of Medicine, Stanford, California, United States
🇺🇸Emory University, Atlanta, Georgia, United States